189 related articles for article (PubMed ID: 33645040)
21. [Primary hepatocarcinoma treated by traditional Chinese medicine combined with transcatheter arterial chemoembolization].
Hou EC; Lu YX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Mar; 29(3):225-7. PubMed ID: 19548439
[TBL] [Abstract][Full Text] [Related]
22. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
[TBL] [Abstract][Full Text] [Related]
23. The effect of TACE in combination with thalidomide-mediated adjuvant therapy on the levels of VEGF and bFGF in patients with hepatocellular carcinoma.
Tong C; Liu H; Chen R; Zhu F
Am J Transl Res; 2021; 13(5):5575-5581. PubMed ID: 34150160
[TBL] [Abstract][Full Text] [Related]
24. Effects of Dahuang zhechong pill on doxorubicin-resistant SMMC-7721 xenografts in mice.
Wu L; Cao KX; Ni ZH; Li WD; Chen ZP; Cheng HB; Liu X
J Ethnopharmacol; 2018 Aug; 222():71-78. PubMed ID: 29609009
[TBL] [Abstract][Full Text] [Related]
25. Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level.
Li X; Feng GS; Zheng CS; Zhuo CK; Liu X
World J Gastroenterol; 2004 Oct; 10(19):2878-82. PubMed ID: 15334691
[TBL] [Abstract][Full Text] [Related]
26. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
Li XQ; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound.
Wang Y; Xuan Z; Zheng X; Han R; Zhou L; Liu H; Liu Y
J BUON; 2019; 24(6):2394-2401. PubMed ID: 31983111
[TBL] [Abstract][Full Text] [Related]
28. Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma.
Zhou Y; Qian Y; Xiong W; Yan N; Hu B; Xiong Z; He W
Emerg Med Int; 2022; 2022():4842370. PubMed ID: 36204334
[TBL] [Abstract][Full Text] [Related]
29. [Effect of transcatheter arterial chemoembolization combined with thymosin alpha 1 on the autophagy of immune cells from advanced hepatocellular carcinoma].
Fang SJ; Zheng LY; Zhao ZW; Fan XX; Xu M; Ji JS
Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(25):1942-1946. PubMed ID: 28693071
[No Abstract] [Full Text] [Related]
30. Efficacy of endostatin combined with continuous transcatheter arterial infusion and chemoembolization on gastric cancer with liver metastasis and analysis of prognosis.
Chen L; Shi H; Che Y; Sun W; Niu X; Lu W
J BUON; 2020; 25(3):1469-1475. PubMed ID: 32862592
[TBL] [Abstract][Full Text] [Related]
31. [Experimental study on effect of dahuang zhechong wan combined with adefovir dipivoxil in preventing hepatic fibrosis in patients with chronic hepatitis B].
Zhang L; Chang Y
Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(6):862-4. PubMed ID: 22715739
[TBL] [Abstract][Full Text] [Related]
32. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
[TBL] [Abstract][Full Text] [Related]
33. Effect of Dahuang zhechong formula on liver fibrosis in patients with chronic hepatitis B: a meta-analysis.
Wei F; Lang Y; Gong D; Fan Y
Complement Ther Med; 2015 Feb; 23(1):129-38. PubMed ID: 25637160
[TBL] [Abstract][Full Text] [Related]
34. [Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma].
Huang R; Li WH; Zhu J; Li CL; Wan HG; Chen LZ
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1164-1168. PubMed ID: 32311881
[No Abstract] [Full Text] [Related]
35. The effects of interventional therapy on serum HTATIP2/TIP30, B7-H4 and short-term curative effect in primary hepatocellular carcinoma.
Zheng ZJ; Fu J; Zhi F; Liu WJ; Guo YJ; Zhu DD; Mo JG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6778-6783. PubMed ID: 30402840
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients.
Ranieri G; Ammendola M; Marech I; Laterza A; Abbate I; Oakley C; Vacca A; Sacco R; Gadaleta CD
World J Gastroenterol; 2015 May; 21(19):6018-25. PubMed ID: 26019468
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of lenvatinib combined with sequential transarterial chemoembolization for primary hepatocellular carcinoma and the effects on serum basic fibroblast growth factor and vascular endothelial growth factor.
Xie QY; Huang LP; Gao FW; Liu DQ; Wang X; Jiang KY; Gong J; Zhao X; Gao BJ; Lei ZH
Front Pharmacol; 2022; 13():965770. PubMed ID: 36339553
[No Abstract] [Full Text] [Related]
38. [Clinical effects of qianggan capsule on the liver tissue pathology and PDGF-BB, TGF-beta1, TIMP-1, and MMP-1 factors in patients with chronic hepatitis B].
Wang H; Yang LM; Huang L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1337-40. PubMed ID: 22097200
[TBL] [Abstract][Full Text] [Related]
39. Study on the material basis of Dahuang Zhechong pill of anti-hepatoma effect by promoting vascular normalization.
Chen H; Yang F; Fu C; Zhang Z; Xu K; Lu S; Chen Z; Wu L; Li W
Biomed Chromatogr; 2022 May; 36(5):e5305. PubMed ID: 34967034
[TBL] [Abstract][Full Text] [Related]
40. Effect of bevacizumab administered prior to transarterial chemoembolization on the therapeutic effects of lenvatinib given post-TACE in primary liver cancer patients.
Dang Z; Jiang L; Huang F
Int J Clin Pharmacol Ther; 2023 Oct; 61(10):423-429. PubMed ID: 37548453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
